Document Detail

Effect of the spinal drug tramadol on the fatty acid compositions of rabbit spinal cord and brain.
MedLine Citation:
PMID:  14519944     Owner:  NLM     Status:  MEDLINE    
Tramadol is an important spinal drug which produces analgesia following intrathecal injection. It is well known that fatty acids (FAs) play an important role in membrane fluidity of the blood-brain barrier (BBB) tissue, which blocks and/or controls the transportation of toxic substances into the brain. The aim of this study was to investigate the effect of a spinal drug (tramadol) on the concentrations and compositions of fatty acid in BBB tissues of New Zealand male rabbits. The total cellular fatty acid profiles of the tissues in three spinal cord sections (cervical, thoracal and lumbar) and in the brain of rabbits with or without drug administration were determined by gas chromatography using Sherlock Microbial Identification System (MIS) software (Microbial ID, Newark, DE, U.S.A.) with a database of FAME profiles for eukary. The relative percentage of the fatty acid methyl ester (FAME), 24 : 1 omega9c nervonic and 17 : 1 omega8c, did not change with tramadol treatments. However, there was an increase in the concentration of the FA 16 : 0, 18 : 1 omega7c DMA, 18 : 1 omega9c, sum in future 4, sum in future 8, sum in future 9, 18 : 0, 20 : 4 omega6c, sum in future 14, 22 : 4 omega6c, in contrast to a decrease in the percentages of the following FAMEs; 20 : 0, 20 : 1 omega9c. In the brain, there was an increase in the concentration of the FA 18 : 1 omega9c, sum in future 8 and 18 : 0, in contrast to a decrease in the percentages of two FAMEs, 16 : 0, 20 : 4 omega6c and 22 : 6 omega3c. The number of fatty acids were 20 in the spinal cord sections and 8 in the brain tissues of control animals compared to 15-18 fatty acids in the spinal cord section and 7 in the brain tissues of drug administered animals. The overall changes in the concentrations and numbers of FAs suggest that the spinal drug tested in this study has a side effect of disrupting of membrane fluidity of the BBB, which may cause neurotoxicity.
Haci Ahmet Alici; Ismail Ozmen; Mehmet Cesur; Fikrettin Sahin
Related Documents :
19013214 - Phosphatidyl ethanolamine with increased polyunsaturated fatty acids in compensation fo...
2892224 - Biochemical aspects of dysphoria: case study for hypothesis generation.
12608694 - Metabolism and functions of phosphatidylserine in mammalian brain.
1954564 - The 1989 borden award lecture. some effects of dietary components (amino acids, carbohy...
542614 - Differential production of prostaglandins within the human uterus.
1138524 - Structural studies of the extracellular polysaccharide produced by the diatom chaetocer...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Biological & pharmaceutical bulletin     Volume:  26     ISSN:  0918-6158     ISO Abbreviation:  Biol. Pharm. Bull.     Publication Date:  2003 Oct 
Date Detail:
Created Date:  2003-10-01     Completed Date:  2004-02-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9311984     Medline TA:  Biol Pharm Bull     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  1403-6     Citation Subset:  IM    
Department of Anesthesiology and Reanimation, Ataturk University, Medical School, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood-Brain Barrier / drug effects,  metabolism
Brain / drug effects*,  metabolism
Fatty Acids / metabolism*
Spinal Cord / drug effects*,  metabolism
Tramadol / pharmacology*
Reg. No./Substance:
0/Fatty Acids; 27203-92-5/Tramadol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Quercetin, a flavonoid antioxidant, prevents and protects against ethanol-induced oxidative stress i...
Next Document:  Synthesis and anticonvulsant activity of novel 1-substituted-1,2-dihydro-pyridazine-3,6-diones.